Learn more about investing in Girihlet

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Girihlet
Immune repertoires
Founded
2012
Employees*
2-10
Funding to Date*
$2.8M
Website
girihlet.com
* Data source: Crunchbase
Anitha Jayaprakash, PhD, CEO
We think measuring your immune system is a more complete window to your health because it’s highly dynamic, predictive, and retains memories of past events.
Your immune system is the first one to detect cancer cells

Girihlet is a multi-dimensional platform that will accelerate the discovery of disease-monitoring and therapeutic strategies for complex immune diseases. We develop personalized therapeutics for autoimmune disorders by accurately and sensitively profiling immune repertoire profiles, based on proprietary assays and computational algorithms.